Healthcare >> CEO Interviews >> October 1, 2001
David Green, President and CEO, has served as Harvard Bioscience, Inc.’s President and a member of the board of directors of the company since March 1996, and as its CEO since June 2013. Prior to joining the company, Mr. Green was a Strategy Consultant with Monitor Company, a strategy consulting company, in Cambridge, Massachusetts, and Johannesburg, South Africa, from June 1991 until September 1995, and a Brand Manager for household products with Unilever PLC, a packaged consumer goods company, in London from September 1985 to February 1989. Mr. Green currently serves on the board of directors of the Harvard Business School Healthcare Alumni Association, the advisory board of the Harvard Business School Student Healthcare Club and on the executive advisory board of the University of Massachusetts Lowell Nanomanufacturing Center. Mr. Green graduated from Oxford University with a Bachelor of Arts with honors in physics and holds a MBA with distinction from Harvard Business School. Profile
TWST: Can we start out with an update on Harvard Bioscience, Inc.?What's gone on since the spring that investors should focus on?
Mr. Green: I think there have been important developments